PAR PHARM INC FDA Approval ANDA 202993

ANDA 202993

PAR PHARM INC

FDA Drug Application

Application #202993

Application Sponsors

ANDA 202993PAR PHARM INC

Marketing Status

None (Tentative Approval)001

Application Products

001CAPSULE;ORAL20MG;10MG0DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATEDEXTROMETHORPHAN HYDROBROMIDE;QUINIDINE SULFATE

FDA Submissions

UNKNOWN; ORIG1TA2015-12-23

Submissions Property Types

ORIG1Null1

CDER Filings

PAR PHARM INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202993
            [companyName] => PAR PHARM INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"DEXTROMETHORPHAN HYDROBROMIDE AND QUINIDINE SULFATE","activeIngredients":"DEXTROMETHORPHAN HYDROBROMIDE;QUINIDINE SULFATE","strength":"20MG;10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"None (Tentative Approval)","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"12\/23\/2015","submission":"ORIG-1","actionType":"Tentative Approval","submissionClassification":"","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2015-12-23
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.